Interestingly, vitamin D3 and analogs have shown efficacy in the treatment of fibrotic skin conditions, including SSc, by inhibiting Th2 cytokine- and TGFβ-induced periostin expression [119]. This evidence concerns the gene TGFB1 and systemic sclerosis.